First-of-its-kind: Drug trial eliminates cancer in every patient
Dinkle Popli
June 8th 2022 10:48 AM --
Updated:
June 8th 2022 02:29 PM
While there’s no absolute cure for cancer, but a small clinical trial may lead the way to a powerful new treatment for rectal tumors. A
study
published Sunday in The New England Journal of Medicine found a 100 percent success rate in 12 patients with rectal cancer treated with the immunotherapy drug dostarlimab. The patients’ tumors disappeared—and there were no severe side effects or signs of the cancer returning.
Also Read|
Sidhu Moosewala Antim Ardas and Bhog to be held in Mansa today
press release
. “They can suffer life-altering bowel and bladder dysfunction, incontinence, infertility, sexual dysfunction, and more.”